Readmissions in Severe Sepsis Common
“Severe sepsis continues to be a common cause of hospitalisation and has the associated high costs,” says lead author Darya Rudym, MD, New York University School of Medicine, New York.
Previous studies have examined some quality measures (eg, length of stay) associated with sepsis, an infection of the bloodstream that can lead to organ failure and death. Dr. Rudym's study specifically looked at the rate of readmission within 30 days after discharge with a diagnosis of severe sepsis. Dr. Rudym and colleagues sought to compare this rate to the readmission rates for Centers for Medicare and Medicaid Services reported outcomes such as acute myocardial infarction (MI), HF and pneumonia.
The research team studied inpatient discharges from Bellevue Hospital in New York City between July 2011 and July 2014 and identified subsequent readmissions to the hospital within 30 days.
During the three-year study period, the team tracked 22,712 discharges, with an overall readmission rate of 15.31 percent (3,477 patients). Based on three different previously reported methods of detecting cases of severe sepsis, namely Angus, Martin, and the explicit International Classification of Diseases-9-CM sepsis codes, 1,801, 798, and 579 patients, respectively, were identified as discharged with severe sepsis. “Of those, 266, 119, and 71 were readmitted within 30 days, accounting for 14.77 percent, 14.91 percent, and 12.26 percent, respectively,” explains Dr. Rudym.
In comparison, the readmission rates for MI, pneumonia and HF were 8.67 percent, 14.46 percent and 15 percent, respectively.
As Dr. Rudym points out: “Readmission rates in severe sepsis are shown not to be significantly different from readmission rates in heart failure and pneumonia.”
Source: American Thoracic Society
Image credit: NHS Direct Wales
Published on : Wed, 20 May 2015
Print as PDF
NovaPort cannulas: The safe access to the vascular system. NovaPort® twin double lumen cannulas are specifically developed for veno-venous vascular access. NovaPort one single lumen cannulas are specifically developed for the percutaneous connection (KU)...
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
The HAMILTON-T1 combines for the first time the functionality of a fully featured intensive care unit ventilator with the compactness and ruggedness required for transport. This is why the HAMILTON-T1 enables you to provide optimal ventilation therapy...